期刊文献+

血浆同型半胱氨酸与老年单纯收缩期高血压 被引量:3

下载PDF
导出
作者 李浩 赵文明
出处 《中国老年学杂志》 CAS CSCD 北大核心 2006年第11期1598-1599,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献23

  • 1Susan C,Louis M,Vivian F.Hyperhomocysteinemia:an emerging and important risk factor for thromboembolic and cardiovascular disease[J].Clin Chem,1996; 106:709-22.
  • 2Perna AF,Castaldo P,Ingrosso D,et al.Homocysteine,a new cardiovascular risk factor[J].J Nephrol,1999; 12:230-40.
  • 3Sutton TK,Bostom A,Sellub J,et al.High homocysteine levels are independently related to isolated systolic hypertension in order adults[J].Circulation,1997; 96 (16):1745.
  • 4Rutan G.Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Triak[J].Circulation,1998 ;77:504.
  • 5李浩,宋春生,刘方州,徐力然,崔玲,罗增刚,刘芳.老年高血压分型与健康老人血浆同型半胱氨酸、神经肽Y及血脂水平的比较研究[J].中国老年学杂志,2003,23(8):496-498. 被引量:25
  • 6汤佩麟,王毓明,李明珍,竺霞霜,刘王明,郑家驹.血浆高半胱氨酸水平和冠心病的关系[J].中国循环杂志,1997,12(5):323-326. 被引量:26
  • 7Mudd SH,Levy HL.Plasma homocyst(e) ine or homocysteine[J].N Engl J Med,1995 ;333:325.
  • 8Tsikas D,Sandmann J,Rossa S,et al.Investigations of S-transnitrosylation reactions between olw-and high-molecular-weight S-nitrosocom-pounds and their thiols by high-performance liquid chromatography and gas chromatography-mas spectrometry[J].Analbiochem,1999 ;270:231-41.
  • 9孙晓楠,李玉明,郭虹.单纯收缩期高血压患者同型半胱氨酸代谢关键酶基因多态性相关因子研究[J].中华心血管病杂志,2003,31(4):269-273. 被引量:60
  • 10Jacob RA,Wu MM,henning SM,et al.Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction[J].J Nutr,1994; 124:1072 -80.

二级参考文献29

  • 1汪海,龙超良,贾国栋,何华美,解卫平,冯华松,胡刚,刘国树.盐酸埃他卡林对内皮素系统的影响[J].中国药理学通报,2005,21(1):33-38. 被引量:11
  • 2Liu Xinguang,Jia Boqi.Department of Gastroenterology, FirstTeaching Hospital, Beijing Medical University, Beijing l00034.低剂量三联疗法根除幽门螺杆菌的多中心临床研究[J].中华消化杂志,1996,16(4):192-195. 被引量:36
  • 3张颖冬 朱志刚 等.血浆Hcy水平及MTHFR基因多态性脑梗死发病中的作用[J].神经生化通讯,2000,13(2):1-5.
  • 4Fryer RH,Wilson BD,Gubler DB et al.Homocysteine,a risk factor for premature vascular disease and thrombosis,induces tissue factor activity in endothelial cells[J].Arterioscler and Thromb,1993,13(9):1327-33.
  • 5Khattar RS,Senior R,Swales JD et al.Value of ambulatory intraarterial blood pressure monitoring in the long-term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension[J].J Hum Hypertens,1999,13(2):111-7.
  • 6Wang H.Pharmacological characteristics of the novel antihypertensive drug,iptakalim hydrochloride,and its molecular mechanisms[J].Drug Dev Res,2003,58(1):65-8.
  • 7Koga T,Claycombe K,Meydani M.Homocysteine increases monocyte and T cell adhesion to human aortic endothelial cells[J].Atherosclerosis,2002,161(2):365-74.
  • 8Sung FL,Siow YL,Wang GP et al.Homocysteine stimulates the expression of monocyte chemoattractant protein1 in endothelial cells leading to enhanced monocyte chemotaxis[J].Mol Cell Biolchem,2001,216(1-2):121-8.
  • 9Silverman MD,Tumuluri RJ,Davis M et al.Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion[J].Arterioscler Thromb Vasc Biol,2002,22(4):587-92.
  • 10Fang J,Madhavan S,Cohen H,et al. Isolated diastolic hypertension: A favorable finding among young and middle-aged hypertensive subject [J]. Hypertension, 1995; 26 : 377-382.

共引文献150

同被引文献27

  • 1苏化庆,杨期明,杨期东.高同型半胱氨酸血症与脑血管疾病发病机制研究进展[J].脑与神经疾病杂志,2005,13(5):397-399. 被引量:27
  • 2郭秋菊.冠心病危险因素的研究进展与健康教育.中华现代护理学杂志,2009,6(24):473-480.
  • 3Hansson GK. Atherosclerosis-an immune disease:the an- itschkov lecture [J]. Atherosclerosis, 2009,202 ( 1 ) : 2-10.
  • 4Van CA, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis [J]. Atherosclerosis, 2009,204 (2) : 321 - 329.
  • 5Shao JS,Sierra OL, Cohen R,et al. Vascular calcification and aortic fibrosis A bifunctional role for osteopontin in diabetic arteriosclerosis [J]. Arteriosclerosis ,Thrombosis, and Vascular Biology,2011,31 (8):1821-1833.
  • 6Callegari A,Coons M,Ricks J,et al. Bone marrow-or vessel wall-derived osteoprotegerin is sufficient to reduce atheroscle- rotic lesion size and vascular calcification [J]. Arterioscle- rosis,Thrombosis,and Vascular Biology, 2013,33 (11 ) : 2491-2500.
  • 7Derwall M,Malhotra R,Lai CS,et al. Inhibition of bone morphogenetic protein signaling reduces vascular calcifi- cation and atheroselerosis [J]. Arteriosclerosis,Thrombosis, and Vascular Biology, 2012,32 (3) : 613-622.
  • 8Renoux C, Dell" Aniello S, Garbe E, et al. Transdermal and oral hormone replacement therapy and the risk of stroke :a nested case-control study [J]. British Medical Journal,2010, 340 : c2519.
  • 9Schierbeck LL,Rejnmark L,Tofteng CL,et al. Effect of hor- mone replacement therapy on cardiovascular events in re- cently postmenopausal women: randomised trial [J]. British Medical Journal, 2012,345 (6409) : 1990-1993.
  • 10Cooney MT,Vartiainen E,Laakitainen T,et al. Elevated rest- ing heart rate is an independent risk factor for cardiovascu- lar disease in healthy men and women [J]. American Heart Journal,2010,159(4) :612-619.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部